New Sky Home Health Care Corp | |
7235 Sw 24 St Ste 204, Miami, Florida 33155 | |
(305) 558-6454 | |
Not Available |
Name | New Sky Home Health Care Corp |
---|---|
Location | 7235 Sw 24 St Ste 204, Miami, Florida |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 103131 |
Ownership Type | Proprietary |
Service Area Zip Codes |
NPI Number | 1073748497 |
Organization Name | ATLANTIS HOME CARE GROUP, INC |
Address | 1490 W 49th Pl, Suite # 365, Hialeah, FL 33012 |
Phone Number | 305-821-0035 |
News Archive
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
The dominant model of disease today is, as 30 years ago, still biomedical, with molecular biology being the basic scientific discipline.
Princeton University researchers have created "souped up" versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.
Generex Biotechnology Corporationannounced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.
Nature reports how "a potential breakthrough in the quest to prevent HIV and AIDS has collided with sensitivities about testing expensive drugs in poor parts of the world."
› Verified 4 days ago
NPI Number | 1457505372 |
Organization Name | SUPER STAR STAFF COORDINATOR SERVICES, INC. |
Address | 1490 W 49th Pl, Ste 445, Hialeah, FL 33012 |
Phone Number | 305-556-2888 |
News Archive
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
The dominant model of disease today is, as 30 years ago, still biomedical, with molecular biology being the basic scientific discipline.
Princeton University researchers have created "souped up" versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.
Generex Biotechnology Corporationannounced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.
Nature reports how "a potential breakthrough in the quest to prevent HIV and AIDS has collided with sensitivities about testing expensive drugs in poor parts of the world."
› Verified 4 days ago
NPI Number | 1497879027 |
Organization Name | AMEN HOME HEALTHCARE, INC. |
Address | 1490 W 49th Pl, Suite 592, Hialeah, FL 33012 |
Phone Number | 305-818-0066 |
News Archive
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
The dominant model of disease today is, as 30 years ago, still biomedical, with molecular biology being the basic scientific discipline.
Princeton University researchers have created "souped up" versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.
Generex Biotechnology Corporationannounced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.
Nature reports how "a potential breakthrough in the quest to prevent HIV and AIDS has collided with sensitivities about testing expensive drugs in poor parts of the world."
› Verified 4 days ago
NPI Number | 1609030030 |
Organization Name | NEW SKY HOME HEALTH CARE CORP |
Address | 1490 W 49th Pl, Ste 310, Hialeah, FL 33012 |
Phone Number | 305-558-6454 |
News Archive
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
The dominant model of disease today is, as 30 years ago, still biomedical, with molecular biology being the basic scientific discipline.
Princeton University researchers have created "souped up" versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.
Generex Biotechnology Corporationannounced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.
Nature reports how "a potential breakthrough in the quest to prevent HIV and AIDS has collided with sensitivities about testing expensive drugs in poor parts of the world."
› Verified 4 days ago
NPI Number | 1700034550 |
Organization Name | M & T HOME HEALTH CARE, INC |
Address | 1490 W 49th Pl, Suite 550, Hialeah, FL 33012 |
Phone Number | 305-819-7871 |
News Archive
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
The dominant model of disease today is, as 30 years ago, still biomedical, with molecular biology being the basic scientific discipline.
Princeton University researchers have created "souped up" versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.
Generex Biotechnology Corporationannounced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.
Nature reports how "a potential breakthrough in the quest to prevent HIV and AIDS has collided with sensitivities about testing expensive drugs in poor parts of the world."
› Verified 4 days ago
NPI Number | 1811133994 |
Organization Name | ROYALTY HOME HEALTH CARE INC |
Address | 1490 W 49th Pl, Suite 209, Hialeah, FL 33012 |
Phone Number | 786-457-7749 |
News Archive
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
The dominant model of disease today is, as 30 years ago, still biomedical, with molecular biology being the basic scientific discipline.
Princeton University researchers have created "souped up" versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.
Generex Biotechnology Corporationannounced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.
Nature reports how "a potential breakthrough in the quest to prevent HIV and AIDS has collided with sensitivities about testing expensive drugs in poor parts of the world."
› Verified 4 days ago
NPI Number | 1861664401 |
Organization Name | ND HEALTH CARE SERVICES INC |
Address | 1490 W 49th Pl, Suite 315, Hialeah, FL 33012 |
Phone Number | 305-364-7010 |
News Archive
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
The dominant model of disease today is, as 30 years ago, still biomedical, with molecular biology being the basic scientific discipline.
Princeton University researchers have created "souped up" versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.
Generex Biotechnology Corporationannounced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.
Nature reports how "a potential breakthrough in the quest to prevent HIV and AIDS has collided with sensitivities about testing expensive drugs in poor parts of the world."
› Verified 4 days ago
NPI Number | 1952433005 |
Organization Name | LIFE HEALTH CARE, INC |
Address | 1490 W 49th Pl, Suite 570, Hialeah, FL 33012 |
Phone Number | 305-826-4420 |
News Archive
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
The dominant model of disease today is, as 30 years ago, still biomedical, with molecular biology being the basic scientific discipline.
Princeton University researchers have created "souped up" versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.
Generex Biotechnology Corporationannounced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.
Nature reports how "a potential breakthrough in the quest to prevent HIV and AIDS has collided with sensitivities about testing expensive drugs in poor parts of the world."
› Verified 4 days ago
Quality Rating: | Not Available* |
* This measure currently does not have data or provider has been certified/recertified for less than 6 months. |
News Archive
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
The dominant model of disease today is, as 30 years ago, still biomedical, with molecular biology being the basic scientific discipline.
Princeton University researchers have created "souped up" versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.
Generex Biotechnology Corporationannounced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.
Nature reports how "a potential breakthrough in the quest to prevent HIV and AIDS has collided with sensitivities about testing expensive drugs in poor parts of the world."
› Verified 4 days ago
News Archive
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
The dominant model of disease today is, as 30 years ago, still biomedical, with molecular biology being the basic scientific discipline.
Princeton University researchers have created "souped up" versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.
Generex Biotechnology Corporationannounced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.
Nature reports how "a potential breakthrough in the quest to prevent HIV and AIDS has collided with sensitivities about testing expensive drugs in poor parts of the world."
› Verified 4 days ago
New Sky Home Health Care Corp Location: 7235 Sw 24 St Ste 204, Miami, Florida 33155 Ratings: NA Phone: (305) 558-6454 | |
E & R Health Care Inc Location: 3955 Sw 137th Avenue Ste 5, Miami, Florida 33175 Ratings: Phone: (305) 468-9544 | |
Cruz Healthcare Corp Location: 10300 Sunset Drive Ste 444, Miami, Florida 33173 Ratings: Phone: (305) 221-9981 | |
Alleanza Health Care Associates Llc Location: 15190 Sw 136th Street Suite 32, Miami, Florida 33196 Ratings: Phone: (305) 238-1441 | |
American Providers, Inc. Location: 2000 Nw 89th Pl, Miami, Florida 33172 Ratings: Phone: (305) 591-9975 | |
Baptist Health Home Care Location: 12400 Sw 127 Ave, Miami, Florida 33186 Ratings: Phone: (786) 596-3010 |